Bristol Myers Squibb to Participate in Upcoming Investor Conferences
25 February 2025 - 10:59PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in two upcoming investor conferences in
March 2025.
The company will participate in a fireside chat at the TD Cowen
45th Annual Health Care Conference on March 4, 2025, at 2:30 p.m.
ET. In addition, the company will take part in a fireside chat at
the Leerink Partners 2025 Global Healthcare Conference on March 12,
2025, at 11:20 a.m. ET.
Investors and the general public are invited to listen to both
sessions at their respective times by visiting
http://investor.bms.com. An archived edition of each session will
be available following its conclusion.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, X, YouTube, Facebook, and Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250225770037/en/
Media: media@bms.com
Investors: investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Jan 2025 to Feb 2025
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Feb 2024 to Feb 2025
